Maximum Dose of Midazolam
For procedural sedation in healthy adults under 60 years, the total dose rarely exceeds 5-6 mg IV, while elderly patients (≥60 years) rarely require more than 3.5 mg total. 1, 2
Procedural Sedation Dosing Limits
Adults Under 60 Years
- Maximum total dose: 5-6 mg IV for procedural sedation in healthy, unpremedicated patients 1, 2
- Initial dose: 1-2 mg IV over at least 2 minutes, then titrate with 1 mg increments every 2-3 minutes to effect 1, 3
- In resistant cases, up to 0.6 mg/kg total dose may be used for anesthesia induction, though this may prolong recovery 2
Elderly Patients (≥60 Years)
- Maximum total dose: 3.5 mg for unpremedicated patients 1, 2
- Initial dose should be reduced to ≤1 mg IV over 2 minutes 1
- Patients over 70 years are particularly sensitive and may require doses so small that overdosage is easily possible 4, 5
- Intramuscular midazolam should be used cautiously under continuous observation in patients ≥70 years due to risk of excessive drowsiness 5
High-Risk Patients
- ASA Physical Status III or greater require 20% or more dose reduction 1
- Patients with hepatic or renal impairment require dose reduction due to decreased clearance 6, 1, 3
- When opioids are co-administered, reduce midazolam dose by 30% due to synergistic respiratory depression 6, 1, 3
Pediatric Maximum Doses
Intramuscular Administration
- Effective dose: 0.1-0.15 mg/kg IM 1
- For higher anxiety: up to 0.5 mg/kg IM 1, 2
- Total dose usually does not exceed 10 mg 2
Intravenous Administration by Age Group
- Ages 6 months to 5 years: Initial 0.05-0.1 mg/kg; maximum total dose up to 0.6 mg/kg (usually not exceeding 6 mg) 2, 7
- Ages 6 to 12 years: Initial 0.025-0.05 mg/kg; maximum total dose up to 0.4 mg/kg (usually not exceeding 10 mg) 2, 7
- Ages 12 to 16 years: Dosed as adults; total dose usually does not exceed 10 mg 2
- Infants <6 months: Limited data available; titrate with small increments as this population is particularly vulnerable to airway obstruction and hypoventilation 2
ICU Continuous Infusion Maximum Rates
Critical Context on Benzodiazepine Use
- Benzodiazepines are no longer preferred for ICU sedation due to association with increased delirium (54% vs 76.6% with dexmedetomidine), longer mechanical ventilation, increased ICU length of stay, and higher mortality 6, 3
- Non-benzodiazepine sedatives (propofol, dexmedetomidine) should be first-line agents 6, 3
When Midazolam Must Be Used in ICU
- Loading dose: 0.01-0.05 mg/kg IV over several minutes 6, 3
- Maintenance infusion: 0.02-0.1 mg/kg/hr (1-8 mg/hr for most adults) 6, 2
- Recent data shows dramatically reduced use, with median doses of 0.0026-0.00476 mg/kg/hr when used as rescue sedation 6
- Titrate to lightest sedation level compatible with safety (RASS -1 to 0) 6
Pediatric ICU Continuous Infusion
- Loading dose: 0.05-0.2 mg/kg IV over at least 2-3 minutes in intubated patients 2
- Maintenance infusion: 0.06-0.12 mg/kg/hr (1-2 mcg/kg/min) 2
- Infusion rate can be increased or decreased by 25% as required 2
Neonatal ICU Continuous Infusion
- No loading dose should be used in neonates 2
- <32 weeks gestation: 0.03 mg/kg/hr (0.5 mcg/kg/min) 2
- >32 weeks gestation: 0.06 mg/kg/hr (1 mcg/kg/min) 2
- Rapid injection should never be used in neonates due to risk of severe hypotension and seizures 2
Anesthesia Induction Maximum Doses
Unpremedicated Adults
- Under 55 years: 0.3-0.35 mg/kg IV; maximum up to 0.6 mg/kg total (though larger doses prolong recovery) 2
- Over 55 years: 0.3 mg/kg IV or less 2
- Severe systemic disease/debilitation: 0.2-0.25 mg/kg; as little as 0.15 mg/kg may suffice 2
Premedicated Adults
- Under 55 years: 0.25 mg/kg IV 2
- Over 55 years (ASA I & II): 0.2 mg/kg IV 2
- Severe systemic disease/debilitation: As little as 0.15 mg/kg may suffice 2
Critical Safety Considerations
Mandatory Precautions
- Flumazenil 0.25-0.5 mg IV must be immediately available for reversal 1, 3
- Administer in 0.1-0.3 mg incremental boluses if needed 6
- Wait 2-3 minutes after each dose before administering additional medication to allow peak effect evaluation 1, 3, 2
- Apnea risk persists up to 30 minutes after last dose, and rapid administration significantly increases apneic episodes 6, 3
Special Population Adjustments
- Obesity requires dose adjustment based on ideal body weight, not actual weight 1, 2
- Hepatic or renal impairment mandates dose reduction due to accumulation of midazolam and active metabolites 6, 1, 3
- Concomitant opioid use requires 30% dose reduction 6, 1, 3
Common Pitfalls to Avoid
- In elderly patients over 70 years, the required dose is often so small that overdosage is extremely easy 4
- Midazolam accumulates in skeletal muscle and fat with repeated dosing, prolonging duration of effect 6, 1
- Children metabolize midazolam more rapidly than adults (clearance 10.0 ± 5.0 ml/min/kg vs lower adult values), requiring higher mg/kg doses 7, 8
- Younger pediatric patients (<6 years) require higher mg/kg doses than older children and closer monitoring 2